Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease
Open Access
- 22 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 10 (1), 1-13
- https://doi.org/10.1038/s41598-020-69164-y
Abstract
Macular Telangiectasia type 2 (MacTel) is an uncommon bilateral retinal disease, in which glial cell and photoreceptor degeneration leads to central vision loss. The causative disease mechanism is largely unknown, and no treatment is currently available. A previous study found variants in genes associated with glycine–serine metabolism (PSPH, PHGDH and CPS1) to be associated with MacTel, and showed low levels of glycine and serine in the serum of MacTel patients. Recently, a causative role of deoxysphingolipids in MacTel disease has been established. However, little is known about possible other metabolic dysregulation. Here we used a global metabolomics platform in a case–control study to comprehensively profile serum from 60 MacTel patients and 58 controls. Analysis of the data, using innovative computational approaches, revealed a detailed, disease-associated metabolic profile with broad changes in multiple metabolic pathways. This included alterations in the levels of several metabolites that are directly or indirectly linked to glycine–serine metabolism, further validating our previous genetic findings. We also found changes unrelated to PSPH, PHGDH and CPS1 activity. Most pronounced, levels of several lipid groups were altered, with increased phosphatidylethanolamines being the most affected lipid group. Assessing correlations between different metabolites across our samples revealed putative functional connections. Correlations between phosphatidylethanolamines and sphingomyelin, and glycine–serine and sphingomyelin, observed in controls, were reduced in MacTel patients, suggesting metabolic re-wiring of sphingomyelin metabolism in MacTel patients. Our findings provide novel insights into metabolic changes associated with MacTel and implicate altered lipid metabolism as a contributor to this retinal neurodegenerative disease.Keywords
Funding Information
- Lowy Medical Research Institute Melbourne International Research Scholarship
- Lowy Medical Research Institute
- DH | National Institute for Health Research
- Lowy Medical Research Institute Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust
- Department of Health | National Health and Medical Research Council
This publication has 65 references indexed in Scilit:
- Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 DiabetesPLOS ONE, 2013
- Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2PLOS ONE, 2012
- Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing SpondylitisMolecular & Cellular Proteomics, 2012
- Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer ProgressionCancer Research, 2011
- Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosaProceedings of the National Academy of Sciences, 2010
- The Prevalence of Macular Telangiectasia Type 2 in the Beaver Dam Eye StudyAmerican Journal of Ophthalmology, 2010
- ROAST: rotation gene set tests for complex microarray experimentsBioinformatics, 2010
- α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic PopulationPLOS ONE, 2010
- Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adultsHuman Molecular Genetics, 2010
- The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) ProjectInvestigative Opthalmology & Visual Science, 2008